Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Themis Medicare, originally founded as Themis Chemicals in 1969, is a prominent Indian pharmaceutical company specializing in the development and manufacture of Active Pharmaceutical Ingredients (APIs) and finished dosage formulations. The company is a leader in therapeutic areas such as pain management, anesthesia, and critical care, and operates a significant joint venture with the Hungarian pharmaceutical firm Gedeon Richter. Headquartered in Mumbai, Themis Medicare maintains state-of-the-art manufacturing facilities in Vapi and Haridwar that comply with international regulatory standards. Their product portfolio includes innovative drug delivery systems and widely recognized brands like E-Mal and Etojet. The company serves both the domestic Indian market and over 40 international territories, focusing on high-quality, affordable healthcare solutions.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Themis Chemicals.